Article info

Download PDFPDF

Original research
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study

Authors

  1. Correspondence to Professor Faysal Dane; faysaldane{at}yahoo.com
View Full Text

Citation

Dane F, Ozgurdal K, Yalçın Ş, et al
Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study

Publication history

  • Received November 13, 2018
  • Revised February 19, 2020
  • Accepted March 2, 2020
  • First published March 26, 2020.
Online issue publication 
March 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.